FOLD Stock Analysis: Buy, Sell, or Hold?
FOLD - Amicus Therapeutics, Inc
$14.44
0.00 (0.00%)
▲
5d:
+0.07%
30d:
+0.77%
90d:
+1.4%
HOLD
MODERATE Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 07, 2026
Get Alerted When FOLD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: FOLD shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: FOLD shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$33.44
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$20.76
30.4% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 18.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: FOLD is currently trading at $14.44, which is considered extended relative to its 30-day fair value range of $14.34 to $14.42. From a valuation perspective, the stock is trading at a discount (Forward PE: 15.7) compared to its historical average (18.7). Remarkably, the market is currently pricing in an annual earnings decline of 5.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, FOLD is in a strong uptrend. The price is currently testing key support at $14.37. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: FOLD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, FOLD is in a strong uptrend. The price is currently testing key support at $14.37. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: FOLD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$14.34 -
$14.42
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
57.1%
Protect Your Profits
Holding FOLD? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($14.50)
Fair Price Analysis
30-Day Fair Range
$14.34 -
$14.42
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$14.37
Resistance Level
$14.46
Current Trend
Strong Uptrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
15.73
Wall Street Target
$14.50
(+0.4%)
Revenue Growth (YoY)
23.7%
Earnings Growth (YoY)
-95.5%
Profit Margin
-4.3%
Valuation Discount vs History
-5.6% cheaper
PE vs Historical
15.7 vs 18.7
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-5.6%
(market-implied from PE analysis)
1-Year Target
$13.63
(-6%)
2-Year Target
$12.87
(-11%)
3-Year Target
$12.15
(-16%)
3-Yr Target (if PE normalizes)
(PE: 16→19)
$14.44
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.6, Growth: 42.0%)
$54.06
(+274%)
Base:
(SPY PE: 15.7, Growth: 42.0%)
$41.33
(+186%)
Bear:
(PE: 13.4, Growth: 42.0%)
$35.13
(+143%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 15.7 to 18.7
Stabilization Target:
$17.17
(+18.9%)
PE Expansion Potential:
+18.9%
Share & Embed Analysis
Last updated: April 05, 2026 2:59 PM ET
Data refreshes hourly during market hours. Next update: 3:59 PM
Data refreshes hourly during market hours. Next update: 3:59 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is FOLD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
12
Sells
Net
INSIDERS SELLING
Recent Transactions
Bradley L Campbell
SELL
22500 shares
2026-03-02
Bradley L Campbell
SELL
75000 shares
2026-01-20
David Michael Clark
SELL
25642 shares
2025-12-19
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$89 | 65 BUY |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$58 | 57 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 61 BUY |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$547 | 50 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$119 | 61 BUY |
Advanced FOLD Option Strategies
Professional options setups generated by AI based on today's FOLD price and gamma walls.
